John Carter
Family Medicine · Tucson, AZNPI 1235187493
Payments from drug & device makers
Across 93 payments — averaging $14.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$266
- Pfizer$204
- Amgen$174
- GSK$111
- Boehringer Ingelheim$108
- Amarin Pharma, Inc.$96
- plus $408 from 15 others
What the payments were for
- Food & beverage$1,367100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 15 | $266 |
| Pfizer | 17 | $204 |
| Amgen | 10 | $174 |
| GSK | 8 | $111 |
| Boehringer Ingelheim | 7 | $108 |
| Amarin Pharma, Inc. | 6 | $96 |
| Sanofi-aventis U.S. LLC | 4 | $61 |
| Novo Nordisk | 4 | $57 |
| Johnson & Johnson | 4 | $54 |
| Astellas Pharma US Inc | 3 | $44 |
| Merck | 3 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Sanofi Pasteur Inc. | 2 | $27 |
| Corcept Therapeutics | 1 | $21 |
| Lilly USA, LLC | 1 | $14 |
| Boston Scientific | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Seqirus USA Inc | 1 | $12 |
| Strongbridge US Inc. | 1 | $12 |
| Abbott | 1 | $12 |
| Fidia Pharma USA Inc. | 1 | $5 |
How this compares
$1,367 in reported general payments places this provider in the 75th percentile of 2,099 family medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 12 | $12,015 |
| EliquisApixaban | 17 | $11,748 |
| Duloxetine Hcl | 44 | $1,868 |
| Rosuvastatin Calcium | 119 | $1,558 |
| Levothyroxine Sodium | 116 | $1,446 |
| Valsartan | 25 | $1,245 |
| Gabapentin | 33 | $1,009 |
| Pantoprazole Sodium | 51 | $908 |
| Bupropion XlBupropion Hcl | 26 | $889 |
| Losartan Potassium | 46 | $781 |
| Amlodipine Besylate | 84 | $692 |
| Omeprazole | 50 | $633 |
| Atorvastatin Calcium | 54 | $603 |
| Tamsulosin Hcl | 30 | $463 |
| Metformin Hcl ErMetformin Hcl | 23 | $432 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $54 | $12,01512 claims |
| PfizerEliquis | $204 | $11,74817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Tucson
- Dena PetersenTucson$14.7M
- John McGettiganTucson$8.3M
- Kevin PoundsTucson$1.9M
- Thili KulatilakeTucson$1.8M
- Judith BrownTucson$399K
- Hannah LeslieTucson$228K
- Charles MichieliTucson$111K
- Danielle ArmasScottsdale$73M
- Terry O'ReillyMesa$35.8M
- Shawn SearleChandler$27M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.